TRED Annual Report FY 2017

21 20 NSU OFFICE OF TECHNOLOGY TRANSFER NSU OFFICE OF TECHNOLOGY TRANSFER 0 2 4 6 8 10 12 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 3 3 3 6 4 4 4 1 3 5 5 8 10 11 8 5 5 8 0 8 0 0 1 1 2 2 2 2 3 2 NSU INVENTION DISCLOSURES AND PATENT APPLICATIONS FY 2008–FY 2017 0 10 20 30 40 50 60 70 80 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 6 14 0 8 19 1 11 11 27 3 17 37 35 4 21 45 6 25 50 9 29 55 11 32 58 66 13 40 77 11 CUMULATIVE NSU INVENTION DISCLOSURES AND PATENT APPLICATIONS FY 2008–FY 2017 Invention Disclosures Cumulative Invention Disclosures Patent Applications Cumulative Patent Applications Patents Issued Cumulative Patents Issued NSU TECHNOLOGIES NSU is able to recognize high-potential technologies, assess their technical and commercial feasibility, secure patent protection, and conduct transactions with commercialization partners for the ultimate benefit of the public. NSU technologies that are ready for commercialization include • portfolio of abuse-deterrent pharmaceutical compositions • diagnostic for genetic mutations • early detection of bed sores • therapies for treatment of heart failure • image compression and encryption • portfolio of small-molecule cancer therapeutics • portfolio of novel drug delivery methods for anaphylaxis • novel method to diagnose complex immune diseases • novel method for modulating oncolytic viruses • wound healing and skin rejuvenation • genetic data for complex diseases